Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Roberts

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Stroke|November 1, 1995
Failure of isradipine to reduce infarct size in mouse, gerbil, and rat models of cerebral ischemiaS J Bailey, N I Wood, N A Samson, et al.
Neuropharmacology|November 1, 1993
SB 201823-A, a neuronal Ca2+ antagonist is neuroprotective in two models of cerebral ischaemiaC D Benham, T H Brown, D G Cooper, et al.
British Journal of Pharmacology|May 6, 2009
Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- miceR X Guo, C Anaclet, J C Roberts, et al.
Epidemics|May 21, 2022
RAMPVIS: Answering the challenges of building visualisation capabilities for large-scale emergency responsesM Chen, A Abdul-Rahman, D Archambault, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 1, 1997
The effects of SB 206284A, a novel neuronal calcium-channel antagonist, in models of cerebral ischemiaN I Wood, F C Barone, C D Benham, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Stroke|November 1, 1995
Failure of isradipine to reduce infarct size in mouse, gerbil, and rat models of cerebral ischemiaS J Bailey, N I Wood, N A Samson, et al.
Neuropharmacology|November 1, 1993
SB 201823-A, a neuronal Ca2+ antagonist is neuroprotective in two models of cerebral ischaemiaC D Benham, T H Brown, D G Cooper, et al.
British Journal of Pharmacology|May 6, 2009
Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- miceR X Guo, C Anaclet, J C Roberts, et al.
Epidemics|May 21, 2022
RAMPVIS: Answering the challenges of building visualisation capabilities for large-scale emergency responsesM Chen, A Abdul-Rahman, D Archambault, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 1, 1997
The effects of SB 206284A, a novel neuronal calcium-channel antagonist, in models of cerebral ischemiaN I Wood, F C Barone, C D Benham, et al.
Pageof 14